Literature DB >> 4750215

Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease.

F Pass, S Goldfischer, I Sternlieb, I H Scheinberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4750215

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  9 in total

1.  Pemphigus foliaceus induced by penicillamine.

Authors:  R A Marsden; R I Vanhegan; M Walshe; H Hill; A G Mowat
Journal:  Br Med J       Date:  1976-12-11

2.  Penicillamine in the treatment of rheumatoid arthritis.

Authors:  A V Camp
Journal:  Proc R Soc Med       Date:  1977-02

3.  [Dermatoses with transepithelial perforation (author's transl)].

Authors:  H Bardach
Journal:  Arch Dermatol Res       Date:  1976-12-15       Impact factor: 3.017

4.  Pseudoxanthoma elasticum-like skin changes induced by penicillamine.

Authors:  R H Meyrick Thomas; N Light; A D Stephens; N C Avery; J D Kirby
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

5.  Elastosis perforans serpiginosa in association with scabies mite.

Authors:  Michael Kassardjian; Julie Frederickson; Jack Griffith; Paul Shitabata; David Horowitz
Journal:  J Clin Aesthet Dermatol       Date:  2013-10

6.  Penicillamine-induced Elastosis Perforans Serpiginosa and Cutis Laxa in a Patient with Wilson's Disease.

Authors:  Se Young Na; Mira Choi; Min Ji Kim; Jong Hee Lee; Soyun Cho
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 7.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

8.  Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.

Authors:  W K Essigman
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

9.  Effect of DL-penicillamine on the aorta of growing chickens. Ultrastructural and biochemical studies.

Authors:  I Pasquali Ronchetti; C Fornieri; M Baccarani Contri; D Quaglino; E Caselgrandi
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.